Please check your internet connection and try again.
# IV Hydrocortisone for Acute Asthma
## Overview
Hydrocortisone is a short-acting systemic corticosteroid often utilized in the acute management of asthma exacerbations when oral administration is not feasible (e.g., severe respiratory distress, vomiting, or intubation). It is generally reserved for patients who cannot tolerate oral prednisone/prednisolone.
## Primary Indications
Systemic management of acute asthma exacerbations requiring hospitalization, specifically when oral therapy is contraindicated or clinical status is rapidly deteriorating.
## Adult Dosing
* **Initial Dose:** 100 mg IV every 6 to 8 hours.
* **Maximum Dose:** No specific maximum, but dosing is titrated based on clinical response and transition to oral therapy.
## Pediatric Dosing
* **Initial Dose:** 5 to 10 mg/kg/dose IV every 6 hours (often capped at 100 mg per dose depending on institutional protocol).
* **Note:** Always consult local pediatric hospital protocols, as dosing guidelines vary slightly between major asthma clinical practice guidelines (e.g., GINA, NAEPP).
## Dose Adjustments
* **Hepatic/Renal Impairment:** No standard dose reduction required for temporary acute management.
* **Transition:** Convert to oral corticosteroids as soon as the patient is able to swallow and tolerates oral intake.
## Contraindications
* Known hypersensitivity to hydrocortisone or any component of the formulation.
* Systemic fungal infections.
* Administration of live or attenuated vaccines while on high-dose therapy.
## Adverse Effects
* **Common:** Hyperglycemia (especially in patients with diabetes), fluid retention, hypertension, and hypokalemia.
* **Neurologic/Psychiatric:** Insomnia, mood swings, or psychosis.
* **Gastrointestinal:** Increased risk of peptic ulcer disease or GI bleeding (rarely with short-term use).
## Key Drug Interactions
* **CYP3A4 Inducers:** (e.g., phenytoin, rifampin) may increase clearance of corticosteroids.
* **Diuretics:** Potential for additive hypokalemia.
* **Warfarin:** Corticosteroids can alter anticoagulation response; monitor INR closely.
## Monitoring
* **Efficacy:** Respiratory rate, oxygen saturation, work of breathing, and peak expiratory flow (PEF) or FEV1 improvement.
* **Safety:** Blood glucose levels (particularly in diabetic patients), blood pressure, and electrolyte status (potassium).
## Clinical Pearls
* **Oral vs. IV:** Oral prednisone/prednisolone is the preferred route for acute asthma; IV hydrocortisone offers no clinical advantage in efficacy and is more expensive.
* **Onset:** Systemic corticosteroids typically take 3–4 hours to show objective clinical improvement; they do not provide immediate bronchodilation.
* **Tapering:** Short courses (e.g., <10–14 days) for acute exacerbations generally do not require a formal taper, but individual clinical judgment should prevail.
***
**Educational Disclaimer:** This information is for educational purposes only. Clinical practice guidelines and local hospital protocols may differ. Always verify dosages, contraindications, and drug interactions with current, institutional-specific prescribing information, electronic medical record resources, or a clinical pharmacist before administration.
